US Patent Issued to Dana-Farber Cancer Institute on May 12 for "Allosteric EGFR inhibitors and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,909, issued on May 12, was assigned to Dana-Farber Cancer Institute Inc. (Boston). "Allosteric EGFR inhibitors and methods of use thereof" w... Read More

US Patent Issued to Janssen Pharmaceutica on May 12 for "Inhibitors of Bruton's tyrosine kinase and methods of their use" (American, Belgian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,910, issued on May 12, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium). "Inhibitors of Bruton's tyrosine kinase and methods of th... Read More

US Patent Issued to CHILDREN'S HOSPITAL MEDICAL CENTER on May 12 for "Methods and compositions for the treatment of pulmonary fibrosis using volasertib" (Ohio Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,911, issued on May 12, was assigned to CHILDREN'S HOSPITAL MEDICAL CENTER (Cincinnati). "Methods and compositions for the treatment of pulmo... Read More

US Patent Issued to GUANGZHOU JOYO PHARMATECH, SHANGHAI JIA TAN PHARMATECH on May 12 for "Application of pyrido[1,2-apyrimidinone analog" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,912, issued on May 12, was assigned to GUANGZHOU JOYO PHARMATECH Co. LTD (Guangdong, China) and SHANGHAI JIA TAN PHARMATECH Co. LTD. (Shangha... Read More

US Patent Issued to APROFOL on May 12 for "Folate salts for medical use" (Swiss Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,913, issued on May 12, was assigned to APROFOL AG (Switzerland). "Folate salts for medical use" was invented by Martin Ulmann (Dachsen, Swit... Read More

US Patent Issued to Douglas Pharmaceuticals on May 12 for "Pharmaceutical rectal suppository compositions of 6-thioguanine, methods of treatment and/or methods of manufacturing" (New Zealander Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,914, issued on May 12, was assigned to Douglas Pharmaceuticals Ltd. (Lincoln, New Zealand). "Pharmaceutical rectal suppository compositions ... Read More

US Patent Issued to VANDA PHARMACEUTICALS on May 12 for "Methods of treating PDE IV-mediated diseases or conditions" (Maryland Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,915, issued on May 12, was assigned to VANDA PHARMACEUTICALS INC. (Washington). "Methods of treating PDE IV-mediated diseases or conditions"... Read More

US Patent Issued on May 12 for "Use of H3K9me3 modulation for enhancing cognitive function" (California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,916, issued on May 12. "Use of H3K9me3 modulation for enhancing cognitive function" was invented by Carl Cotman (Santa Ana, Calif.), Larry O... Read More

US Patent Issued to ADLAI NORTYE BIOPHARMA on May 12 for "High-activity Wnt pathway inhibitor compound" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,917, issued on May 12, was assigned to ADLAI NORTYE BIOPHARMA Co. LTD. (Hangzhou, China). "High-activity Wnt pathway inhibitor compound" was... Read More

US Patent Issued to Amgen on May 12 for "Formulations and dosages for administering a compound that inhibits MCL1 protein" (California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,918, issued on May 12, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Formulations and dosages for administering a compound that inhib... Read More

• ««
• «
• 116793
• 116794
• 116795
• 116796
• 116797
• 116798
• 116799
• 116800
• 116801
• 116802
• »
• »»